跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
CAXATIN CONCENTRATE FOR SOLUTION FOR INTRAVENOUS INFUSION 150MG/15ML - PPB Drug Approval Details
Approvals
/
PPB
/
CAXATIN CONCENTRATE FOR SOLUTION FOR INTRAVENOUS INFUSION 150MG/15ML
Approved
STANDARD
CAXATIN CONCENTRATE FOR SOLUTION FOR INTRAVENOUS INFUSION 150MG/15ML
Lotus Pharmaceutical HK Limited
🇰🇪 Pharmacy and Poisons Board
Approval Date
Jun 21, 2024
Approval ID
f6e1e6063fcd30c9
Company
Lotus Pharmaceutical HK Limited
Type
Standard
Approval Details
Approval Id
f6e1e6063fcd30c9
Product Name
CAXATIN CONCENTRATE FOR SOLUTION FOR INTRAVENOUS INFUSION 150MG/15ML
Drug Hk Name
CAXATIN CONCENTRATE FOR SOLUTION FOR INTRAVENOUS INFUSION 150MG/15ML
Registration Code
HK-63794
Company Name
Lotus Pharmaceutical HK Limited
Company Detail Path
/organization/lotus-pharmaceutical-hk-limited
Registration Category
Part 1, Schedule 1 & Schedule 3 Poison
Sale Requirement
Prescription only Medicines
Registration Date
2015-07-07
Company Address
2/F, JONSIM PLACE, NO.228 QUEEN'S ROAD EAST, WAN CHAI, HONG KONG
Active Ingredients
Approved
Quick Info
Agency
PPB
Country
🇰🇪
Approval Date
Jun 21, 2024
Approval ID
f6e1e6063fcd30c9
Type
Standard
Back to PPB Approvals